Due to the key role of TREM-1 in amplifying the inflammatory response, TREM-1 was identified as an essential regulator of innate immunity in sepsis syndrome (9, 10), and it was confirmed to be an attractive target for the treatment of sepsis (6, 11–14). Here, TREM1 is linked to systemic inflammatory response syndrome.